Clinical observation of stapokibart in patients under 18 years of age with seasonal allergic rhinitis: a case series study of 20 cases
In this small case series, stapokibart rapidly and effectively alleviated nasal symptoms of SAR in children and adolescents, and may provide long-term symptom control across allergy seasons for patients with comorbid AD. The treatment demonstrated a good safety profile, offering novel insights into targeted therapy of comorbid allergic diseases in children.
Authors
- Guodong Hao
- Long-Fei Wang (ORCID: https://orcid.org/0000-0002-8585-9054)
- Chen-xing Kan
- Wei-cong Ma
Institutions
- Tangshan People's Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2026-02-27
- DOI
- https://doi.org/10.3389/falgy.2026.1785270
- Primary Topic
- Allergic Rhinitis and Sensitization
- Type
- article
- Field-Weighted Citation Impact
- 0.00